There is a national issue with the supply of some ADHD medications, including:
- Methylphenidate
- Equasym XL® 10, 20 and 30 mg capsules
- Concerta XL® 54 mg tablet
- Xaggitin XL® 18 and 36 mg tablets
- Xenidate XL® 27 mg tablets
- Lisdexamfetamine
- Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules
- Elvanse® Adult 30, 50, and 70 mg capsules
- Guanfacine
- Intuniv® 1, 2, 3 and 4 mg tablets
- Atomoxetine.
If you are taking any of these medications, your ADHD medicine prescriber will contact you to review your situation and advise the most appropriate option for you. Once you have been in contact with your healthcare professional, they will contact you again when further information is available.
Please do not share your medication with anyone else or stop your medication suddenly.
If your needs are very complex, for example you have mental health problems, or your ADHD symptoms causes you severe difficulty, you can discuss this with your GP, and they may recommend a specialist consultant review.
Supplies of these products are expected to be reinstated gradually from October 2023. Some supplies may be unpredicatable until February 2024. Patients should not attend hospital pharmacies to collect their ADHD medications.
Anyone who is currently waiting to be prescribed ADHD medication will not receive any until stocks are available.
A non-clinical helpline is available if you would like more information on the issue: please call 01634 335095 option 3 then option 3, ADHD Medicine Shortages.